LEADER 01541nam  2200337   450 
001 9910688578303321
005 20230628174153.0
035   $a(CKB)5400000000040481
035   $a(NjHacI)995400000000040481
035   $a(EXLCZ)995400000000040481
100   $a20230628d2019      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBurden of Respiratory Syncytial Virus Infection in the Young /$fedited by Bernhard Resch
210  1$aLondon, England :$cIntechOpen,$d2019.
215   $a1 online resource (108 pages)
311   $a1-83962-252-0 
330   $aRespiratory syncytial virus (RSV) causes seasonal epidemics during the winter and wet seasons, particularly in young children. Although there is one drug available for prophylaxis, palivizumab, it is indicated for high-risk children only. Therefore a vaccine is urgently needed. This book provides an overview of RSV and discusses its incidence and presentation in different populations, including preterm infants and children with congenital heart disease. It also discusses future strategies for RSV prophylaxis and developments in and barriers to creating a viable vaccine.
606   $aViruses
615  0$aViruses.
676   $a579.2
702   $aResch$b Bernhard
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688578303321
996   $aBurden of Respiratory Syncytial Virus Infection in the Young$93201661
997   $aUNINA